Using Community Health Navigators to Advance Cancer Screening Adherence

Completed · Not applicable

Conditions studied: Cancer, Deafness

In brief

Intervention to promote cancer screenings among deaf, deafblind, and hard of hearing participants who have not received screening within the recommended guideline.

Key facts

Study ID

NCT06492993

Run by

Gallaudet University

People needed

184

Starts

2023-09-30

Expected to finish

2026-03-20

Last updated by the study team

2026-04-02

Who can join

Age: 45 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and lifestyle considerations (see Section 5.3, Lifestyle Considerations) and availability for the duration of the study
• Male or female at birth age 45-80yo or female at birth age 45-80yo; age-eligible according to screening criteria
• Self-reported diagnosis of bilateral hearing loss at birth or prior to 13 years old (defined as "early deafness") and use ASL
• Willingness to adhere to the CHN clinical trial regimen
• Willingness to provide cancer screening verification documentation; this will be reviewed during the informed consent procedure
• Access to necessary resources to support video-based communication
• Non-adherent to one or more cancer screening guidelines for breast, lung, prostate, colon, cervical cancers will be those who reported not having had the appropriate recommended screenings within the past year to cancer screening questions in the HINTS-ASL survey

You may not qualify if…

• Presence of full ability to hear in one or both ears beyond 13 years of age
• Younger or older than the age cutoff for the recommended cancer screening
• Not capable of independently conducting the activities of daily living
• In compliance with age- or risk-specific screening at the time of evaluation for study eligibility
• Are currently undergoing cancer treatment or being evaluated for the presence of cancer at the time of evaluation for study eligibility
• Will be engaged in more than 21 consecutive days of travel during the eleven-month study window
• Knows other participants at baseline

Where it is running

• Gallaudet University — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.